Eric P. Leip
Impact in
-
- Blood Pressure and Hypertension Studies
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 51
- Chronic Myeloid Leukemia Treatments 36
- Multiple Myeloma Research and Treatments 13
- Genetics 33
- Chronic Lymphocytic Leukemia Research 33
- Co-authors
- Martin G. Larson (25 shared papers)Daniel Levy (24 shared papers)Ramachandran Srini Vasan (19 shared papers)Emelia J. Benjamin (12 shared papers)Thomas J. Wang (9 shared papers)Ralph B. D’Agostino (7 shared papers)William B. Kannel (4 shared papers)Philip A. Wolf (4 shared papers)
- Journals
- Blood (19 papers)Circulation (9 papers)HemaSphere (6 papers)American Journal of Hematology (4 papers)Leukemia (3 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Eric P. Leip
78 papers receiving 16.0k citations
Eric P. Leip's Hit Papers
Peers
Comparison fields: 5 of 158
- Cardiology and Cardiovascular Medicine 9.0k
- Hematology 2.2k
- Genetics 1.3k
- Endocrinology, Diabetes and Metabolism 1.2k
- Nephrology 433
Countries citing papers authored by Eric P. Leip
This map shows the geographic impact of Eric P. Leip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric P. Leip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric P. Leip more than expected).
Fields of papers citing papers by Eric P. Leip
This network shows the impact of papers produced by Eric P. Leip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric P. Leip. The network helps show where Eric P. Leip may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric P. Leip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lifetime Risk for Development of Atrial Fibrillation Hit paper breakdown → | 2004 | 1649 |
| 2 | Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease Hit paper breakdown → | 2001 | 1634 |
| 3 | Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality Hit paper breakdown → | 2003 | 1622 |
| 4 | Lifetime Risk for Developing Congestive Heart Failure Hit paper breakdown → | 2002 | 1290 |
| 5 | Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death Hit paper breakdown → | 2004 | 1278 |
| 6 | Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging? Hit paper breakdown → | 2001 | 1116 |
| 7 | Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age Hit paper breakdown → | 2006 | 1049 |
| 8 | Impact of Obesity on Plasma Natriuretic Peptide Levels Hit paper breakdown → | 2004 | 853 |
| 9 | Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study Hit paper breakdown → | 2001 | 850 |
| 10 | 2004 | 445 | |
| 11 | Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results Hit paper breakdown → | 2023 | 444 |
| 12 | 2002 | 428 | |
| 13 | 2002 | 403 | |
| 14 | 2011 | 396 | |
| 15 | Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial Hit paper breakdown → | 2017 | 383 |
| 16 | 2012 | 269 | |
| 17 | 2005 | 224 | |
| 18 | 2005 | 169 | |
| 19 | 2004 | 151 | |
| 20 | 2005 | 149 |
About Eric P. Leip
Eric P. Leip is a scholar working on Hematology, Genetics, Rheumatology, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health, having authored 80 papers that have together received 16.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (36 papers), Chronic Lymphocytic Leukemia Research (33 papers), Eosinophilic Disorders and Syndromes (16 papers), Multiple Myeloma Research and Treatments (13 papers), Acute Lymphoblastic Leukemia research (8 papers), Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (5 papers) and Blood Pressure and Hypertension Studies (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (9.0k citations), Hematology (2.2k citations), Genetics (1.3k citations), Endocrinology, Diabetes and Metabolism (1.2k citations) and Nephrology (433 citations). Eric P. Leip has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Martin G. Larson, Daniel Levy, Ramachandran Srini Vasan, Emelia J. Benjamin, Thomas J. Wang, Ralph B. D’Agostino, William B. Kannel, Philip A. Wolf, Donald M. Lloyd‐Jones and Peter Wyman Ford Wilson. Their work appears in journals such as Blood, Circulation, HemaSphere, American Journal of Hematology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.